[Automatic translation follows] Official page of Dijon metropolis. Dijon métropole is a French metropolis, located in the Côte-d'Or department and the Bourgogne-Franche-Comté region. It brings together 23 municipalities. This local authority was created on April 28, 2017 by transformation of the urban community of Greater Dijon.

Sectors: French metropolis

Promoting Innovation and Opportunity in the Burgundy-Franche-Comté Region of France L'AER Bourgogne-Franche-Comté accompagne les entreprises et les territoires. Elle a pour mission : - d'accompagner le maintien et le développement de l'activité économique et l'emploi sur le territoire, - de promouvoir l'attractivité du territoire, - de soutenir et de développer l'innovation et l'éco-innovation. Investment Promotion, Economic Development, International Trade and Development , Hydrogen, Luxury Goods, Wind Energy , Health and Wellness, Agri-food, Digital, Aerospace, Corporate Expansion, Business Expansion, Corporate Relocation, and Foreign Investment

[Automatic translation follows] Welcome to the official LinkedIn account of the Burgundy-Franche-Comté Region. Close to its inhabitants throughout the territory, the Burgundy-Franche-Comté Region acts on a daily basis for everyone: from training to energy transition, from economic development to transport, from high schools to agriculture, youth to European funds, from sport to tourism. # The Region in a few figures - Population: 2.807 million, - Area: 47,784 km2, - Active population 2013: 1,287,926 people, - 8 departments: Côte-d’Or, Doubs, Haute-Saône, Jura, Nièvre, Saône-et-Loire, Territoire de Belfort, Yonne, - Municipalities: 3,831, including 25 municipalities with more than 10,000 inhabitants, - Density: …

Sectors: National and local authorities

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients.

Sectors: Biotechnology French Cluster Public business cluster

Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: …

Sectors: Biotechnology Startup accelerator & VC

[Automatic translation follows] Real Estate Bank SOCFIM - La Banque des Promoteurs - has been for 30 years the entity of Groupe BPCE dedicated to supporting real estate operators with their real estate development, renovation and restructuring projects of buildings. Present throughout France, relying on regional banks (Caisses d'Epargne, Banques Populaires), it operates in all asset categories (housing, offices, shops, logistics, etc.). It is one of the main players in the financing market for real estate professionals: real estate developers, property dealers, developers and operators. With a team of experts entirely focused on the development of its customers, SOCFIM continues …

Sectors: Bank

The CEA is the French Alternative Energies and Atomic Energy Commission ("Commissariat à l'énergie atomique et aux énergies alternatives"​). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and …

Sectors: Research

Eurazeo is a leading global investment group Eurazeo is a leading global investment company, with a diversified portfolio of €34.1 billion in assets under management, including nearly €24.1 billion from third parties, invested in 590 companies. With its considerable private equity, private debt as well as real estate and infrastructure asset expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 410 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free …

Sectors: Finance

[Automatic translation follows] INNOVATION CATALYST SATT SAYENS is a Simplified Joint Stock Company (SAS) whose shareholders are Bpifrance, the University of Burgundy, the University of Franche-Comté, the University of Lorraine, the Technological University of Troyes, the Institut Agro Dijon, the University of Technology of Belfort Montbéliard, ENSMM, CNRS and Inserm. The 2 main activities of SATT SAYENS: - investment in intellectual property and the maturation of innovations from research laboratories in its territory, - as well as the management of partnership research on behalf of the research laboratories of the University of Burgundy and the Institut Agro Dijon. Find our …

Tags: SATT Network Sectors: Research Startup accelerator & VC

Construisons dans un monde qui bouge. CIC is the fourth largest banking group in France, consisting of seven regional banks which operate across France through a network of 1,844 branches employing 24,000 staff. CIC's customer base includes 2.7 million retail clients. One in eleven self-employed professionals is a CIC group client and nearly one in three companies banks with CIC Group. Banque de détail, Banque de financement, Activités de marchés, Banque privée, Capital-développement, Crédit, Assurance, Mobile, Automobile, and Télésurveillance

Sectors: Bank

We are dedicated to therapeutic progress to serve patient needs. Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and …

Sectors: Pharmaceutical